These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7193975)

  • 1. The metabolism of cis-dichlorodiammineplatinum (II): distribution, clearance, and toxicity.
    Lagasse LD; Pretorius RG; Petrilli ES; Ford LC; Hoeschele J; Kean C
    Am J Obstet Gynecol; 1981 Apr; 139(7):791-8. PubMed ID: 7193975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the iv and ip routes of administration of cisplatin in dogs.
    Pretorius RG; Petrilli ES; Kean CK; Ford LC; Hoeschele JD; Lagasse LD
    Cancer Treat Rep; 1981; 65(11-12):1055-62. PubMed ID: 7197584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.
    Litterst CL; LeRoy AF; Guarino AM
    Cancer Treat Rep; 1979; 63(9-10):1485-92. PubMed ID: 498147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II).
    Belt RJ; Himmelstein KJ; Patton TF; Bannister SJ; Sternson LA; Repta AJ
    Cancer Treat Rep; 1979; 63(9-10):1515-21. PubMed ID: 498151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II).
    DeSimone PA; Yancey RS; Coupal JJ; Butts JD; Hoeschel JD
    Cancer Treat Rep; 1979 Jun; 63(6):951-60. PubMed ID: 466654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
    Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
    Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.
    Litterst CL; Gram TE; Dedrick RL; Leroy AF; Guarino AM
    Cancer Res; 1976 Jul; 36(7 PT 1):2340-4. PubMed ID: 1277140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of heavy metal chelators on the renal accumulation of platinum after cis-dichlorodiammineplatinum II administration to the rat.
    Graziano J; Jones B; Pisciotto P
    Br J Pharmacol; 1981 Jul; 73(3):649-54. PubMed ID: 6265016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy.
    Los G; Mutsaers PH; van der Vijgh WJ; Baldew GS; de Graaf PW; McVie JG
    Cancer Res; 1989 Jun; 49(12):3380-4. PubMed ID: 2720692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man.
    Patton TF; Himmelstein KJ; Belt R; Bannister SJ; Sternson LA; Repta AJ
    Cancer Treat Rep; 1978 Sep; 62(9):1359-62. PubMed ID: 688279
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacokinetics of cis-dichlorodiammineplatinum (II)].
    Horiuchi M; Inuyama Y; Kohno N; Mashino S; Fujii M
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):632-7. PubMed ID: 6892197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cis- and trans-dichlorodiammineplatinum(II) on human tumor cell proliferation in diffusion chambers in vivo.
    Ambrose KR; Lowrey JS
    Cancer Res; 1982 May; 42(5):1769-73. PubMed ID: 7039818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of time of cisplatin administration on its toxicity and pharmacokinetics in dogs.
    Hardie EM; Page RL; Williams PL; Fischer WD
    Am J Vet Res; 1991 Nov; 52(11):1821-5. PubMed ID: 1686160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and metabolism of a cisplatin/serum protein complex.
    Cole WC; Wolf W
    Chem Biol Interact; 1980 May; 30(2):223-35. PubMed ID: 7190078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of peritoneal carcinosis with intraperitoneal administration of cis-diamminedichloroplatinum and systemic sodium thiosulfate protection. Clinical results of a pilot study and pharmacokinetics].
    Ehninger G; Rückle H; Haag C; Wilms K
    Onkologie; 1985 Aug; 8(4):202-6. PubMed ID: 3912689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary excretion of platinum in a patient treated with cis-dichlorodiammineplatinum (II).
    Shelley MD; Fish RG; Adams M
    Antimicrob Agents Chemother; 1985 Feb; 27(2):275-6. PubMed ID: 4039121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and safety of targeted cisplatin delivery to a select lung lobe in dogs via the AeroProbe intracorporeal nebulization catheter.
    Selting K; Waldrep JC; Reinero C; Branson K; Gustafson D; Kim DY; Henry C; Owen N; Madsen R; Dhand R
    J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):255-68. PubMed ID: 18759657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and tissue chamber fluid platinum concentrations released from cis-diamminedichloroplatinum II-impregnated polymethylmethacrylate in healthy dogs.
    Buss MS; Henry CJ; Tyler JW; Tobias KS; Daoud S; Hoopes J; Moore MP
    Am J Vet Res; 1999 Mar; 60(3):280-3. PubMed ID: 10188807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.